| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Ray Debanjan is a Chief Financial Officer at CytomX Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $23K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2018 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 3,000 | $15.00 | $45,000.00 | -33.6% | |
| Nov 1, 2018 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 3,000 | $15.00 | $45,000.00 | -33.6% | |
| Oct 1, 2018 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 3,000 | $18.46 | $55,380.00 | -33.6% | |
| Sep 4, 2018 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 3,000 | $22.39 | $67,170.00 | -33.6% | |
| Aug 1, 2018 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 3,000 | $26.05 | $78,150.00 | -33.6% | |
| Jul 2, 2018 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 3,000 | $22.56 | $67,680.00 | -33.6% | |
| Jun 1, 2018 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 3,000 | $25.93 | $77,793.00 | -33.6% | |
| May 1, 2018 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 3,000 | $26.52 | $79,562.10 | -38.8% | |
| Apr 2, 2018 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 3,000 | $28.12 | $84,360.00 | -38.8% | |
| Mar 2, 2018 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 33,000 | $29.99 | $989,694.50 | -61.2% |